Importance of Smell Loss to Patients With Chronic Rhinosinusitis With Nasal Polyps: Options for Management and Recovery
Clinical and Translational Allergy · 2026-02 · 16 (2)
DOI: 10.1002/clt2.70149 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Allergy, online erschienen am 31.01.2026. Verfasst von Thomas S Higgins und 9 weiteren Autor:innen. Beteiligte Einrichtung: Kentuckiana ENT, A Division of ENT Care Centers, Louisville, Kentucky, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regeneron Pharmaceuticals, Sanofi.
Abstract (Originalsprache)
Primary diffuse type 2‐dominant chronic rhinosinusitis with nasal polyps (CRSwNP) is an inflammatory disease of the nasal cavity and paranasal sinuses associated with significant morbidity. Impaired sense of smell is a cardinal symptom of CRSwNP and one of the most burdensome for patients, impacting quality of life, mental health, and even safety. Mechanisms of smell loss in CRSwNP may be related to conductive losses due to significant burden of nasal polyps, as well as the impact of type 2 inflammatory mediators on olfactory sensory neurons. Initial medical management frequently involves intranasal or oral corticosteroids. Patients whose symptoms remain uncontrolled by medical treatment may be offered sinonasal surgery; however, patients may experience recurrence of smell loss following surgery. Guidelines recommend biologics for certain patients with CRSwNP after undergoing complete endoscopic sinus surgery, and data from clinical trials and real‐world evidence support their effectiveness in improving sense of smell. Given the impact of smell loss, shared decision‐making is important in identifying treatment options best suited to achieving patient goals. This review provides an overview of the importance of smell loss in CRSwNP and its known mechanisms, and reviews the evidence for the efficacy of current treatment options in restoring sense of smell.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Kentuckiana ENT, A Division of ENT Care Centers, Louisville, Kentucky, USA.
- Department of Otolaryngology-Head and Neck Surgery, University of Louisville School of Medicine, Louisville, Kentucky, USA.
- Department of Otorhinolaryngology-Head & Neck Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Otorhinolaryngology, Head and Neck Surgery, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
- Department of Otorhinolaryngology and Head and Neck Surgery, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.
- Department of Otorhinolaryngology, Düsseldorf University Hospital (UKD), Düsseldorf, Germany.
ORCID-Profile: Thomas S Higgins
Förderung
- Regeneron Pharmaceuticals
- Sanofi
Zitieren
APA
Higgins, T. S., Douglas, J. E., Kern, R. C., Palmer, J. N., Reitsma, S., Wagenmann, M., Goodman, R., Corbett, M., Almansa, C., & Radwan, A. (2026). Importance of Smell Loss to Patients With Chronic Rhinosinusitis With Nasal Polyps: Options for Management and Recovery. Clinical and Translational Allergy, 16(2). https://doi.org/10.1002/clt2.70149
Vancouver
Higgins TS, Douglas JE, Kern RC, Palmer JN, Reitsma S, Wagenmann M, et al. Importance of Smell Loss to Patients With Chronic Rhinosinusitis With Nasal Polyps: Options for Management and Recovery. Clinical and Translational Allergy. 2026;16(2). doi:10.1002/clt2.70149
BibTeX
@article{Higgins2026,
author = {Higgins, Thomas S and Douglas, Jennifer E and Kern, Robert C and Palmer, James N and Reitsma, Sietze and Wagenmann, Martin and Goodman, Rhea and Corbett, Mark and Almansa, Cristina and Radwan, Amr},
title = {Importance of Smell Loss to Patients With Chronic Rhinosinusitis With Nasal Polyps: Options for Management and Recovery},
journal = {Clinical and Translational Allergy},
year = {2026},
volume = {16},
number = {2},
doi = {10.1002/clt2.70149}
}
EUVIMED